Company Filing History:
Years Active: 2005-2013
Title: Hoh Gyu Hahn: Innovator in Calcium Channel Modulation
Introduction
Hoh Gyu Hahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of calcium channel modulators. With a total of 3 patents to his name, his work has the potential to impact therapeutic treatments for various diseases.
Latest Patents
Hahn's latest patents include innovative compounds that serve as calcium channel modulators. The first patent, titled "Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof," discloses novel imidazolylalkylcarbonyl derivatives that are useful in modulating calcium channels. This patent also outlines a method for treating diseases by administering these compounds based on their inhibitory activity against calcium channels.
The second patent, "Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof," relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts. These compounds are effective as calcium channel modulators, and the patent details a method for their manufacturing. Additionally, it discusses the medicinal use of these compounds for therapeutic treatment of diseases due to their modulatory effects.
Career Highlights
Hoh Gyu Hahn is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development work. His innovative approach to drug design and development has positioned him as a key figure in his field.
Collaborations
Hahn collaborates with notable colleagues, including Kee Dal Nam and Kyung Il Choi. Their combined expertise enhances the research efforts at the Korea Institute of Science and Technology.
Conclusion
Hoh Gyu Hahn's contributions to the field of calcium channel modulation through his patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant therapeutic advancements in treating diseases related to calcium channel dysfunction.